Patch-Type Granuloma Annulare with Clinical and Histological Features of Morphea: A True Overlap?

Main Article Content

Carlie Reeves
Lauryn M Falcone
Collen J Beatty
Viktoryia Kazlouskaya
Joseph English III


granuloma annulare, morphea


A 67-year-old woman was evaluated for a worsening asymptomatic rash located on her torso, back, and legs. She denied any chills or fevers, and reported feeling otherwise well. Clinically, large brownish, slightly atrophic plaques were seen on the torso suggestive of either morphea or a granulomatous condition. Histopathologic examination revealed an increase in interstitial histiocytes infiltrating between altered collagen fibers, palisaded granulomas with increased mucin, suggestive of granuloma annulare (GA), as well as dermal sclerosis, perineural infiltrates with plasma cells and diminished CD34 counts, that are more typical for localized scleroderma/morphea. Morphea and patch-type GA may be indistinguishable clinically and share some histopathological features. This case demonstrates similarities between these conditions and features of both conditions in the same patient.


1. Schmieder SJ, Harper CD, Schmieder GJ. Granuloma Annulare. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 18, 2022.

2. Ben-Amitai D, Hodak E, Lapidoth M, David M. Coexisting morphoea and granuloma annulare-are the conditions related? Clin Exp Dermatol. 1999 Mar;24(2):86-9. doi: 10.1046/j.1365-2230.1999.00425.x. PMID: 10233660.

3. Agrawal P, Pursnani N, Jose R, Farooqui M. Granuloma annulare: A rare dermatological manifestation of diabetes mellitus. J Family Med Prim Care. 2019 Oct 31;8(10):3419-3421. doi: 10.4103/jfmpc.jfmpc_616_19. PMID: 31742181; PMCID: PMC6857419.

4. Khanna U, North JP. Patch-type granuloma annulare: An institution-based study of 23 cases. J Cutan Pathol. 2020 Sep;47(9):785-793. doi: 10.1111/cup.13707. Epub 2020 Apr 27. PMID: 32279342.

5. Dhaliwal CA, MacKenzie AI, Biswas A. Perineural inflammation in morphea (localized scleroderma): systematic characterization of a poorly recognized but potentially useful histopathological feature. J Cutan Pathol. 2014 Jan;41(1):28-35. doi: 10.1111/cup.12242. Epub 2013 Oct 24. PMID: 24117981.

6. Holmes RC, Meara RH. Morphoea, sclerotic panatrophy and disseminated granuloma annulare. Clin Exp Dermatol. 1983 Mar;8(2):201-3. doi: 10.1111/j.1365-2230.1983.tb01767.x. PMID: 6851242.

7. Ağırgöl Ş, Yöntem Ö, Leblebici C, Akbulut TÖ, Demir FT, Türkoğlu Z. Coexistence of morphea and granuloma annulare: a rare case report. Sao Paulo Med J. 2019 Jan-Feb;137(1):96-99. doi: 10.1590/1516-3180.2017.0091060617. Epub 2017 Nov 17. PMID: 29166431.

8. Christensen A, Di Loreto C, Smitaman E, Paravar T, Jones KA, Guma M. Granulomatous fasciitis followed by morphea profunda: Is granulomatous fasciitis part of a spectrum of deep morphea? A case report and review of the literature. Clin Case Rep. 2018 Jun 4;6(8):1412-1417. doi: 10.1002/ccr3.1608. PMID: 30147873; PMCID: PMC6098999.

9. Adigun R, Goyal A, Hariz A. Systemic Sclerosis. 2022 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 28613625.

10. Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear Antibodies in Systemic Sclerosis: an Update. Clin Rev Allergy Immunol. 2020 Feb;58(1):40-51. doi: 10.1007/s12016-018-8718-8. PMID: 30607749.

11. Grabell D, Hsieh C, Andrew R, Martires K, Kim A, Vasquez R, Jacobe H. The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV. J Am Acad Dermatol. 2014 Sep;71(3):493-8. doi: 10.1016/j.jaad.2014.04.009. Epub 2014 May 28. PMID: 24880663; PMCID: PMC4135004.

12. Barbieri JS, Rosenbach M, Rodriguez O, Margolis DJ. Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms. JAMA Dermatol. 2021 Jul 1;157(7):817-823. doi: 10.1001/jamadermatol.2021.1805. PMID: 34106218; PMCID: PMC8190702.

13. Min MS, Wu J, He H, Sanz-Cabanillas JL, Del Duca E, Zhang N, Renert-Yuval Y, Pavel AB, Lebwohl M, Guttman-Yassky E. Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways. J Am Acad Dermatol. 2020 Jul;83(1):63-70. doi: 10.1016/j.jaad.2019.12.028. Epub 2019 Dec 20. PMID: 31870914.

14. Jindal R, Shirazi N, Chauhan P. Histopathology of morphea: Sensitivity of various named signs, a retrospective study. Indian J Pathol Microbiol 2020;63:600-3

15. Joshi TP, Duvic M. Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options. Am J Clin Dermatol. 2022 Jan;23(1):37-50. doi: 10.1007/s40257-021-00636-1. Epub 2021 Sep 8. PMID: 34495491; PMCID: PMC8423598.

16. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014 Jun;32(6):1380-9. doi: 10.1002/stem.1661. PMID: 24497003; PMCID: PMC4260088.

17. Sartori-Valinotti JC, Tollefson MM, Reed AM. Updates on morphea: role of vascular injury and advances in treatment. Autoimmune Dis. 2013;2013:467808. doi: 10.1155/2013/467808. Epub 2013 Nov 12. PMID: 24319593; PMCID: PMC3844232.

18. Borretta, Lisa J. MD*,†; Crawford, Richard I. MD*,† CD34 Staining in Disorders of Collagen Degeneration Other Than Morphea, The American Journal of Dermatopathology: August 2020 - Volume 42 - Issue 8 - p 623-624. doi: 10.1097/DAD.0000000000001584

19. Lee JS, Park HS, Yoon HS, Chung JH, Cho S. CD34 stromal expression is inversely proportional to smooth muscle actin expression and extent of morphea. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2208-2216. doi: 10.1111/jdv.15120. Epub 2018 Jul 6. PMID: 29888507.